TABLE 2.
List of primers and probes used in this work
Gene or probe | Forward primer | Reverse primer | Size (bp) | Reference or origina |
---|---|---|---|---|
Genes | ||||
aggR | 5′-GTATGAAATTAAAACAA ACATCG-3′ | 5′-GTTTATTGGCTTTTAAAATAG TC-3′ | 800 | This study |
aggA | 5′-AAATATGAGAAGAAAGAA-3′ | 5′-AAAAATTAATTCCGGTATGG-3′ | 500 | This study |
aafA | 5′-CAGAATGTTTGCGATTGCTAC-3′ | 5′-TTTGTCACAAGCTCAGCATT-3′ | 468 | This study |
agg3A | 5′-GTATCATTGCGAGTCTGGTAT TCAG-3′ | 5′-GGGCTGTTATAGAGTAACTTCC AG-3′ | 462 | 5 |
hdaA | 5′-TCCATTATGTCAGGCTGCAA-3′ | 5′-GGCGTTAACGTCTGATTTCC-3′ | 411 | This study |
hdaABCD | 5′-TCGCTGGGAAAGTTA AAT GG-3′ | 5′-TTTGCTGTGGTTTTTGTTG-3′ | 3,498 | This study |
aggC | 5′-GTGATCCCCCAAGCTACAGA-3′ | 5′-ATCCCAATGCATTACCCTGA-3′ | 850 | This study |
aafC | 5′-AACGGATACGCCAAGTGTTC-3′ | 5′-GCACCTGTGGTGAGAGGAAT-3′ | 496 | This study |
agg3C | 5′-GTT TGGAAC CGGGAA TTA ACA TTG-3′ | 5′-ATACTTTAGATACCC CTC ACG CAG-3′ | 485 | 5 |
hdaC | 5′-GGGGGAGGGAATAGATATGG-3′ | 5′-CTCATCAGAGCCCACACTCA-3′ | 700 | This study |
aaiC | 5′-ATTGTCCTCAGGCATTTCAC-3′ | 5′-ACGACAACCCCTGATAAACAA-3′ | 215 | CVD collection |
pet | 5′-ACTGGCGGACTCATTGCTGT-3′ | 5′-GCGTTTTTCCGTTCCCTATT-3′ | 800 | CVD collection |
setA | 5′-CCCTGATATTCCAGGGACAT-3′ | 5′-ATGGAAGTCAGCGTCTTTCA-3′ | 134 | 4 |
astA | 5′-ATGCCATCAACACAGTATAT-3′ | 5′-GCGAGTGACGGCTTTGTAGT-3′ | 110 | CVD collection |
aap | 5′-ATGAAAAAAATTAA GTTTGTTATCTT-3′ | 5′-TTATTTAACCCATTCG GTTAGAGC-3′ | 356 | 56 |
cat | 5′-CTGGATATACCACCGTTG ATATA-3′ | 5′-GGGTGAACACTATCCCATAT-3′ | 100 | 4 |
cdtABC | 5′-AATTGTAAATCCTTTGGGGCG TTC-3′ | 5′-GATCTAGGGTGCAAGGGGCT ATT-3′ | 2,009 | This study |
aafCI | 5′-TCTGACGGCGTGTAGTTCTCA CCCA-3′ | This study | ||
aafCIV | 5′-GTCTATAGGGCAAGACAGCG TGAAG-3′ | This study | ||
agg3CII | 5′-CATCACCCCCTAAAAGGGAC ACTG-3′ | This study | ||
agg3CIII | 5′-AGGCCCGAACTCATGCACGTT AT-3′ | This study | ||
Probes | ||||
AAF/I | 5′-AAATATGAGAAGAAAGAA-3′ | 5′-AAAAATTAATTCCGGTATGG-3′ | This study | |
AAF/II | 5′-CAGAATGTTTGCGATTGCTAC-3′ | 5′-TTTGTCACAAGCTCAGCATT-3′ | This study | |
AAF/III | 5′-GTATCATTGCGAGTCTGGTAT TCAG-3′ | 5′-GGGCTGTTATAGAGTAACTTCC AG-3′ | This study |
CVD, Center for Vaccine Development.